Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIp Group Regulatory News (IPO)

Share Price Information for Ip Group (IPO)

Share Price is delayed by 15 minutes
Get Live Data
68.40    0.40 (0.59%)
Bid:
68.30
Ask:
68.60
Spread: 0.30 (0.439%)
Market Cap: £604.26m
IPO Live PriceLast checked at - London Stock Exchange

Intraday Ip Group Share Chart

Transaction in Own Shares

29 Jan 2024 18:13

RNS Number : 2816B
IP Group PLC
29 January 2024
 

Transaction in Own Shares

 

IP Group plc (LSE: IPO) ("IP Group" or "the Group"), today announces that Numis Securities Limited (which is trading for these purposes as Deutsche Numis) ("Deutsche Numis"), purchased on behalf of IP Group the number of ordinary shares of 2 pence each on the London Stock Exchange as set out in the table below (the Repurchased Shares) pursuant to the IP Group share buyback programme announced on 18th December 2023 (the Buyback Programme).

Date of purchase:

29/01/2024

Number of ordinary shares purchased:

56,868

Highest price paid per ordinary share (GBp):

55.30

Lowest price paid per ordinary share (GBp): 

54.60

Volume weighted average price paid per ordinary share (GBp): 

55.0497

 

The Group will hold the Repurchased Shares in treasury. Following the above transaction, the Group holds 27,823,919 of its ordinary shares in treasury and has 1,063,188,005 ordinary shares in issue (including treasury shares). Therefore, the total number of ordinary shares with voting rights will be 1,035,364,086 which may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, IP Group under the FCA's Disclosure Guidance and Transparency Rules.

 

IP Group will make further announcements following the completion of any additional purchases pursuant to the Buyback Programme.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), the schedule below contains detailed information about the purchases made by Deutsche Numis on behalf of IP Group as part of the Buyback Programme.

 

Both aggregate data in respect of the Repurchased Shares as well as the individual purchases are set out below.

 

Aggregate information:

 

Issuer name and ISIN: IP Group plc (ISIN: GB00B128J450)

 

Date of purchases:

29/01/2024

Number of ordinary shares purchased:

56,868

Volume weighted average price (pence):

55.0497

 

Individual transactions:

 

Number of ordinary shares purchased

Transaction price(GBp share)

Time of transaction (UK Time)

Trading venue

3900

55.30

 09:00:02

XLON

1721

55.30

 09:00:02

XLON

4731

54.90

 09:26:44

XLON

60

54.90

 11:38:11

XLON

148

54.90

 12:42:03

XLON

5

54.90

 12:42:03

XLON

911

55.00

 12:42:03

XLON

141

55.20

 12:57:13

XLON

4989

55.20

 12:57:13

XLON

1

55.10

 13:31:16

XLON

1030

55.10

 13:31:16

XLON

1137

55.00

 13:32:47

XLON

4612

55.00

 13:32:47

XLON

187

55.30

 14:55:17

XLON

2949

55.30

 15:00:04

XLON

4644

55.30

 15:00:04

XLON

3298

55.30

 15:00:04

XLON

4852

55.30

 15:00:04

XLON

5440

54.70

 15:32:06

XLON

2817

54.60

 16:05:15

XLON

1946

54.60

 16:05:15

XLON

2000

54.90

 16:16:14

XLON

1239

54.90

 16:16:14

XLON

4110

54.90

 16:16:14

XLON

 

 

For more information, please contact:

 

IP Group plc

www.ipgroupplc.com

Liz Vaughan-Adams, Communications

+44 (0) 20 7444 0062/+44 (0) 7967 312125

Portland

Vic Wallin

+44 (0) 7973 823119

Alex Donaldson

+44 (0) 7516 729702

 

Further information on IP Group is available on our website: www.ipgroupplc.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSMZGZMRLMGDZM
Date   Source Headline
3rd Jun 20267:00 amRNSHolding(s) in Company
2nd Jun 20267:00 amRNSHolding(s) in Company
29th May 20267:00 amRNSHolding(s) in Company
29th May 20267:00 amRNSHolding(s) in Company
28th May 20267:00 amRNSHolding(s) in Company
13th May 20265:30 pmRNSNotice of AGM
12th May 20269:10 amRNS-REnterprise reports positive results from P2 trial
11th May 20264:25 pmRNSHolding(s) in Company
11th May 20264:19 pmRNSHolding(s) in Company
7th May 20267:00 amRNSAppointment of Chair Designate
23rd Apr 202612:18 pmRNSDirector/PDMR Shareholding
21st Apr 20267:00 amRNS-RFirst Light announces £25m successful first close
15th Apr 20265:00 pmRNSAnnual Financial Report
14th Apr 20269:25 amRNSHolding(s) in Company
30th Mar 20262:00 pmRNSNew climate fund launch with Australia's CEFC
26th Mar 202610:00 amRNSHolding(s) in Company
25th Mar 20262:00 pmRNSHolding(s) in Company
19th Mar 20265:30 pmRNSHolding(s) in Company
17th Mar 20267:00 amRNSIP Group plc 2025 Annual Results Release
17th Mar 20267:00 amRNSIP Group plc 2025 Annual Results Release
13th Mar 20265:45 pmRNSHolding(s) in Company
12th Mar 202611:00 amRNSHolding(s) in Company
12th Mar 20269:00 amRNSNotice of Results
12th Mar 20269:00 amRNSNotice of Results
4th Mar 20267:00 amRNS-RPortfolio company Oxa raises $103m in Series D
26th Feb 20262:53 pmRNSHolding(s) in Company
26th Feb 20269:30 amRNSHolding(s) in Company
25th Feb 20265:51 pmRNSHolding(s) in Company
11th Feb 20269:01 amRNS-RMicrobiotica announces positive P1b trial results
30th Jan 20267:00 amRNSHolding(s) in Company
29th Jan 20267:00 amRNSHolding(s) in Company
20th Jan 202612:36 pmRNSHolding(s) in Company
14th Jan 20267:00 amRNSDirectorate change
14th Jan 20267:00 amRNSHolding(s) in Company
12th Jan 20266:25 pmRNSHolding(s) in Company
7th Jan 20262:06 pmRNSPulmocide announces termination of Phase 3 study
2nd Jan 20267:00 amRNSHolding(s) in Company
2nd Jan 20267:00 amRNSHolding(s) in Company
18th Dec 20254:13 pmRNSHolding(s) in Company
18th Dec 20254:13 pmRNSHolding(s) in Company
8th Dec 20257:00 amRNSHolding(s) in Company
5th Dec 20255:26 pmRNSHolding(s) in Company
4th Dec 20254:13 pmRNSHolding(s) in Company
1st Dec 20255:37 pmRNSTotal Voting Rights
20th Nov 20257:00 amRNSCompletion of share buyback programme
19th Nov 20257:00 amRNSTransaction in Own Shares
18th Nov 20257:00 amRNSTransaction in Own Shares
17th Nov 20251:10 pmRNSArtios completes oversubscribed $115m financing
14th Nov 20255:47 pmRNSTransaction in Own Shares
14th Nov 20258:20 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.